Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Forecasted to Post Q2 2024 Earnings of ($0.58) Per Share
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Investment analysts at B. Riley issued their Q2 2024 EPS estimates for Actinium Pharmaceuticals in a report released on Wednesday, May 1st. B. Riley analyst Y. Zhi expects that the biotechnology company will earn ($0.58) per share for the quarter. The consensus estimate for Actinium Pharmaceuticals’ current […]
More Stories
Ultrapar Participações (NYSE:UGP) Shares Down 2.6% – Time to Sell?
Shares of Ultrapar Participações S.A. (NYSE:UGP – Get Free Report) were down 2.6% on Thursday . The stock traded as...
Ultrapar Participações (NYSE:UGP) Shares Down 2.6% – Time to Sell?
Shares of Ultrapar Participações S.A. (NYSE:UGP – Get Free Report) were down 2.6% on Thursday . The stock traded as...
Reddit (NYSE:RDDT) Hits New 12-Month High – Here’s Why
Reddit, Inc. (NYSE:RDDT – Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday . The...
Reddit (NYSE:RDDT) Hits New 12-Month High – Here’s Why
Reddit, Inc. (NYSE:RDDT – Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday . The...
Canadian Solar (NASDAQ:CSIQ) Trading Down 2.5% – Should You Sell?
Canadian Solar Inc. (NASDAQ:CSIQ – Get Free Report) shares were down 2.5% during mid-day trading on Thursday . The company...
Canadian Solar (NASDAQ:CSIQ) Trading Down 2.5% – Should You Sell?
Canadian Solar Inc. (NASDAQ:CSIQ – Get Free Report) shares were down 2.5% during mid-day trading on Thursday . The company...